Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan
Crossref DOI link: https://doi.org/10.1007/s10147-017-1108-z
Published Online: 2017-03-14
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shimomura, Akihiko
Kondo, Shunsuke
Kobayashi, Noriko
Iwasa, Satoru
Kitano, Shigehisa
Tamura, Kenji
Fujiwara, Yutaka
Yamamoto, Noboru
License valid from 2017-03-14